OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
23 sept. 2024 08h00 HE
|
OPKO Health, Inc.
WESTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. (NASDAQ: OPK) company, today announced the appointment of Giovanni Abbadessa, M.D., Ph.D. as Chief...
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results
07 août 2024 16h06 HE
|
OPKO Health, Inc.
MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2024. Highlights from the...
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
01 août 2024 16h05 HE
|
OPKO Health, Inc.
MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2024 after the close of the U.S....
OPKO Health Announces $100 Million Share Repurchase Program
18 juil. 2024 08h00 HE
|
OPKO Health, Inc.
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's...
OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
17 juil. 2024 16h14 HE
|
OPKO Health, Inc.
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by...
OPKO Health to Participate in the Jefferies Global Healthcare Conference
31 mai 2024 10h48 HE
|
OPKO Health, Inc.
MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024...
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
07 mai 2024 16h05 HE
|
OPKO Health, Inc.
MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business...
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
03 mai 2024 08h00 HE
|
OPKO Health, Inc.
MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S....
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
05 mars 2024 08h52 HE
|
OPKO Health, Inc.
• Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans• Candidate showed similar half-life to standard monoclonal...
OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
27 févr. 2024 16h05 HE
|
OPKO Health, Inc.
MIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2023. Business highlights...